http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102123738-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1224e3c07b7cc5684ee81d9e1e5ee15c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0056 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
| filingDate | 2009-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_312de15a163adb46f804217701c3aba7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1708d38c6b85cd02ffc9560eb22d75b9 |
| publicationDate | 2011-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102123738-A |
| titleOfInvention | Methods for detecting dysplasia |
| abstract | The present invention provides imaging methods that can be used to determine the site of dysplasia in patients with Barrett's esophagus. This method involves the use of an optical imaging agent containing a vector that targets the extracellular region of EGFR, which is also selective for EGFR over Her2. The carrier is labeled with an optical reporter suitable for in vivo imaging with light from green to near infrared wavelengths 500-1200 nm. Novel optical imaging agents suitable for use in the method are also provided. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115010850-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115010850-A |
| priorityDate | 2008-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.